Other Viruses Citation List: August 28 - September 10, 2015

Hepatitis B Virus

1. Design, Synthesis, and Biological Evaluation of New N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine Derivatives as Potent anti-HBV Agents. Lv, Z., W. He, X. Tian, J. Kang, Y. Liu, Y. Peng, L. Zheng, Q. Wang, W. Yu, and J. Chang. European Journal of Medicinal Chemistry, 2015. 101: p. 103-110. PMID[26119991].

[PubMed]. OV_0828-091015.

Hepatitis C Virus

2. Novel Benzidine and Diaminofluorene prolinamide Derivatives as Potent Hepatitis C Virus NS5A Inhibitors. Bae, I.H., H.S. Kim, Y. You, C. Chough, W. Choe, M.K. Seon, S.G. Lee, G. Keum, S.K. Jang, and B. Moon Kim. European Journal of Medicinal Chemistry, 2015. 101: p. 163-178. PMID[26134551].

[PubMed]. OV_0828-091015.

3. Design, Synthesis and Evaluation of Novel anti-HCV Molecules that Deliver Intracellularly Three Highly Potent NS5A Inhibitors. Boucle, S., S. Tao, F. Amblard, R.A. Stanton, J.H. Nettles, C. Li, T.R. McBrayer, T. Whitaker, S.J. Coats, and R.F. Schinazi. Bioorganic & Medicinal Chemistry Letters, 2015. 25(17): p. 3711-3715. PMID[26099532].

[PubMed]. OV_0828-091015.

4. Discovery of a Series of Novel Compounds with Moderate anti-Hepatitis C Virus NS3 Protease Activity in Vitro. Shi, F., Y. Zhang, and W. Xu. Bioorganic & Medicinal Chemistry, 2015. 23(17): p. 5539-5545. PMID[26238980].

[PubMed]. OV_0828-091015.

Citations from the ISI Web of Knowledge Listings for O.V.

5. Synthesis and Antiviral Evaluation of a Novel Series of Homoserine-based Inhibitors of the Hepatitis C Virus NS3/4A Serine Protease. Alexandre, F.R., G. Brandt, C. Caillet, D. Chaves, T. Convard, M. Derock, D. Gloux, Y. Griffon, L. Lallos, F. Leroy, M. Liuzzi, A.G. Loi, L. Moulat, C. Musiu, C. Parsy, H. Rahali, V. Roques, M. Seifer, D. Standring, and D. Surleraux. Bioorganic & Medicinal Chemistry Letters, 2015. 25(18): p. 3984-3991. ISI[000359747700045].

[WOS]. OV_0828-091015.